Sree Pharma Solution Private Limited

Sree Pharma Solution Private Limited - pharma in Kolkata, West Bengal, India. FY 2026 financials & compliance.
CIN U24232WB2010PTC141050 Incorporated 14 January 2010 ROC Kolkata HQ Kolkata, West Bengal, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹8.99 Lakh
▼ 12% YoY
Net profit · FY 2025
₹3,089
Net margin 0.3%
EBITDA · FY 2025
₹6,990
EBITDA margin 0.8%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
16 yrs
Est. 2010
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Sree Pharma Solution Private Limited

Data last updated:

Sree Pharma Solution Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 14 January 2010 and has been in existence for over 16 years.

The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24232WB2010PTC141050. Its GSTIN is 19AANCS9041H1ZV (West Bengal).

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Kalyan Kumar Ghosh and Subir Dutta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 128/1 B. L. Ghosh Road, Kolkata, West Bengal, India – 700057.

As per the financials filed for FY 2025, the company reported a revenue of ₹8.99 Lakh, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹3,089 (net margin 0.3%) and EBITDA of ₹6,990 (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 54% over three years and 33% over five years.

Court records list 5 cases involving the company, including 5 filed against it; 5 cases are pending.

The current compliance status is marked as active non-compliant by the Registrar of Companies.

Company details

CIN U24232WB2010PTC141050
Registration Number 141050
Incorporation Date 14 January 2010
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Non-Compliant

Contact details

Sree Pharma Solution Private Limited's registered office is in Kolkata, West Bengal. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    128/1 B. L. Ghosh Road, Kolkata, West Bengal, India – 700057
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Sree Pharma Solution Private Limited, buy the company report.

Comprehensive company report
Sree Pharma Solution Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Sree Pharma Solution is trade. In detail, this covers wholesale trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG1Wholesale Trading

To see the full business activity and turnover split of Sree Pharma Solution Private Limited, buy the company report.

Financials of Sree Pharma Solution Private Limited

FY 2025 filings available

Sree Pharma Solution Private Limited reported revenue of ₹8.99 Lakh (down 12% YoY) for FY 2025.

Revenue · FY 2025
₹8.99 Lakh ▼ 12%
Net profit · FY 2025
₹3,089 margin 0.3%
EBITDA · FY 2025
₹6,990 margin 0.8%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 54%
5 years · compounded
▼ 33%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 50%
5 years · compounded
▼ 25%

Revenue has declined at a compounded annual rate (CAGR) of 33% over five years, including a 12% fall in the latest year. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹6,990
Profit Before Tax
Tax Expense
Net Profit (PAT)₹3,089
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin0.8%
Net Profit Margin0.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Sree Pharma Solution Private Limited, buy the company report.

Board of directors of Sree Pharma Solution Private Limited

Sree Pharma Solution has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Kalyan Kumar GhoshDirector11 Jun 20188 Years 4 MonthsCurrent
Subir DuttaDirector17 Jul 20188 Years 3 MonthsCurrent

Peer comparison

Sree Pharma Solution Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Sree Pharma Solution Private Limitedthis company₹8.99 Lakh (FY 2025)₹3,0890.3%-12.0%Kolkata, West Bengal, India
Pharmestra Biotech Private Limited₹8.97 Lakh (FY 2024)Delhi, India
Actovis Life Care Private Limited₹8.94 Lakh (FY 2022)-44.0%Vadodara, Gujarat, India
Transgenic Pharmaceuticals Private Limited₹8.94 Lakh (FY 2025)6.0%Indore, Madhya Pradesh, India

To see the full peer comparison of Sree Pharma Solution Private Limited, buy the company report.

Shareholding

The shareholding of Sree Pharma Solution Private Limited is on record for FY 2015, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2015
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Sree Pharma Solution Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Sree Pharma Solution Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Sree Pharma Solution has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
19AANCS9041H1ZVWest BengalActive01 Jul 2017

To see the full GST registrations and return filing status of Sree Pharma Solution Private Limited, buy the company report.

Recent activity

Sree Pharma Solution Private Limited has 5 board changes on record since 2013: 2 appointments and 3 cessations. The latest: Anima Dutta ceased to be Director on 14 Nov 2022.

AGM
Sree Pharma Solution Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sree Pharma Solution Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata Ii.
Ceased
Anima Dutta ceased to be Director.
Ceased
Kalpana Dutta ceased to be Director.
Appointed
Subir Dutta was appointed as Director.
Appointed
Kalyan Kumar Ghosh was appointed as Director.
Ceased
Subir Dutta ceased to be Director.
Incorporation
14 Jan 2010
Sree Pharma Solution Private Limited was registered on 14 Jan 2010 with Roc Kolkata Ii & aged 16 years 9 months as per MCA records.

Frequently asked questions

Sree Pharma Solution is an active private limited company based in Kolkata, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 14 January 2010 (16+ years old) and is registered under CIN U24232WB2010PTC141050.

Sree Pharma Solution has 2 current directors:

The latest financial statements of Sree Pharma Solution on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Sree Pharma Solution is 19AANCS9041H1ZV, registered in West Bengal.

The CIN (Corporate Identification Number) of Sree Pharma Solution is U24232WB2010PTC141050. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sree Pharma Solution has 5 court cases on record: 5 filed against it. 5 are pending.

Sree Pharma Solution was incorporated on 14 January 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kolkata.

The peers of Sree Pharma Solution by revenue are Pharmestra Biotech Private Limited, Actovis Life Care Private Limited, Transgenic Pharmaceuticals Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).

Anima Dutta ceased to be Director on 14 Nov 2022. Kalpana Dutta ceased to be Director on 14 Nov 2022. Subir Dutta was appointed as Director on 17 Jul 2018. Sree Pharma Solution has 5 board changes on record in total.

The registered office of Sree Pharma Solution is at 1281 B. L. Ghosh Road, Kolkata, West Bengal, India – 700057.

Sree Pharma Solution operates in the pharma industry, in the drug formulation and development segment.